article thumbnail

India Remakes Global Innovation

Harvard Business Review

In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. In a global market that includes both affluent and mass market consumers, and in a world of polycentric innovation, firms will need to master and integrate both structured and flexible approaches to innovation.